BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa

Search

Drug Impact Events

Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
2/22/17 Celgene (CELG) Revlimid for Multiple Myeloma (MM) Subscribers Only Subscribers Only Subscribers Only
2/22/17 Ocular Therapeutix (OCUL) Dextenza for Ocular Inflammation (Ophthalmology) Subscribers Only Subscribers Only Subscribers Only
2/22/17 Argos Therapeutics (ARGS) AGS-003 for Renal Cell Cancer (RCC) Subscribers Only Subscribers Only Subscribers Only
2/21/17 Pfizer (PFE) Inotuzumab Ozogamicin for Acute Lymphocytic Leukemia (ALL) Subscribers Only Subscribers Only Subscribers Only
2/21/17 Cidara Therapeutics (CDTX) CD101 (Topical) for Fungal Infections - Non-Systemic Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

Expected
Date Range
Lead
Company
Drug Expected
Catalyst
02/23/17 Subscribers Only Subscribers Only Trial Data - Updated Results
02/23/17 Subscribers Only Subscribers Only Trial Data - Updated Results
02/23/17 Subscribers Only Subscribers Only Trial Data - Top-Line Results
02/23/17 Subscribers Only Subscribers Only Trial Data - Updated Results
02/23/17 Subscribers Only Subscribers Only Trial Data - Top-Line Results